TrialThe oncologist2020
A Phase II Trial of Cabozantinib in Hormone Receptor-Positive Breast Cancer with Bone Metastases.
Jing Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this papercites it
TrialThe oncologist2020
Jing Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.